Assessing Fecal Contamination in Groundwater from the Tulum Region, Quintana Roo, Mexico

The Yucatan Peninsula’s groundwater is experiencing increases in degradation due to swelling population and tourism; yet little is known about sources and transport of contaminants in drinking water supplies. The karst allows for rapid transport of microbial and chemical contaminants to the subsurface, resulting in significantly increased potential for pollution of groundwater. The objective of this research is to determine the occurrence, source, and extent of fecal con- tamination in the Tulum region of the Peninsula. A multi-analytical approach was undertaken in impacted and unim- pacted groundwater locations; measurements included physicochemical parameters, total coliform and E. coli, Bacter- oides (human vs total) and caffeine. The results indicate a variation in geochemistry from impacted to protected sites. The total coliform and E. coli show fecal contamination is wide spread. However, the presence of human Bacteriodes and caffeine in the water in the Tulum well field indicates that the recent human activities next to the well field are im- pacting the drinking water supply. This project is an assessment of the area’s current water quality conditions and the probable impact that the aforementioned growth would have on the area’s water supply. By applying multiple source parameter measurements, including molecular microbiology and chemical indicators it was confirmed the extent of fe- cal contamination of human origin covered the entire sampling region.Funding for this research was provided by Northern Illinois University’s Center for Latino and Latin American Studies, the Geology and Environmental Geosciences de- partment, and Library. This work was also funded by the United States Department of Agriculture, Agricultural Re- search Service, Water Management Conservation and Re- search Program. This article is made openly accessible in part by an award from the Northern Illinois University Libraries’ Open Access Publishing Fund

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

Background: COVID-19 has been associated with a broad range of thromboembolic, ischemic, and hemorrhagic complications (coagulopathy complications). Most studies have focused on patients with severe disease from high-income countries (HICs). Objectives: The main aims were to compare the frequency of coagulopathy complications in developing countries (low- and middle-income countries [LMICs]) with those in HICs, delineate the frequency across a range of treatment levels, and determine associations with in-hospital mortality. Methods: Adult patients enrolled in an observational, multinational registry, the International Severe Acute Respiratory and Emerging Infections COVID-19 study, between January 1, 2020, and September 15, 2021, met inclusion criteria, including admission to a hospital for laboratory-confirmed, acute COVID-19 and data on complications and survival. The advanced-treatment cohort received care, such as admission to the intensive care unit, mechanical ventilation, or inotropes or vasopressors; the basic-treatment cohort did not receive any of these interventions. Results: The study population included 495,682 patients from 52 countries, with 63% from LMICs and 85% in the basic treatment cohort. The frequency of coagulopathy complications was higher in HICs (0.76%-3.4%) than in LMICs (0.09%-1.22%). Complications were more frequent in the advanced-treatment cohort than in the basic-treatment cohort. Coagulopathy complications were associated with increased in-hospital mortality (odds ratio, 1.58; 95% CI, 1.52-1.64). The increased mortality associated with these complications was higher in LMICs (58.5%) than in HICs (35.4%). After controlling for coagulopathy complications, treatment intensity, and multiple other factors, the mortality was higher among patients in LMICs than among patients in HICs (odds ratio, 1.45; 95% CI, 1.39-1.51). Conclusion: In a large, international registry of patients hospitalized for COVID-19, coagulopathy complications were more frequent in HICs than in LMICs (developing countries). Increased mortality associated with coagulopathy complications was of a greater magnitude among patients in LMICs. Additional research is needed regarding timely diagnosis of and intervention for coagulation derangements associated with COVID-19, particularly for limited-resource settings

The value of open-source clinical science in pandemic response: lessons from ISARIC

International audienc